1-4 of 4
Kathleen M Aguilar
Close
Sort by
Journal Articles

Recent Patterns of Care with BTK Inhibitors and Distribution of Social Determinants of Health Among Patients with CLL/SLL in the US Community Setting

David J Andorsky, Ira Zackon, Thomas W Wilson, Kathleen M Aguilar, Chuck Wentworth, Yunfei Wang, Scott Goldfarb, Keri Yang, Erlene Kuizon Seymour, Mark Balk, Gregory A Maglinte
Journal: Blood
Blood (2023) 142 (Supplement 1): 2413.
https://doi.org/10.1182/blood-2023-172880
Published: 2023
Journal Articles

Characteristics, Blood Counts, Treatments, and Clinical Outcomes of 5871 Patients with Polycythemia Vera Treated in US Community Practices

Roger M. Lyons, Kathleen M. Aguilar, Lavanya Sudharshan, Divea Venkatasetty, Juliet Ndukum, Ira Zackon, Jingbo Yu
Journal: Blood
Blood (2022) 140 (Supplement 1): 13310–13311.
https://doi.org/10.1182/blood-2022-163416
Published: 2022
Journal Articles

Safety of Split First Dosing Vs Standard Dosing Administration of Daratumumab Among Multiple Myeloma Patients Treated in a US Community Oncology Setting: A Real-World Observational Study

Robert M Rifkin, MD, David Singer, PharmD, Kathleen M. Aguilar, MPH, Bismark Baidoo, PhD, Eric M Maiese, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4846.
https://doi.org/10.1182/blood-2018-99-116808
Published: 2018
Journal Articles

Clinical Profiles, Treatment Characteristics and Outcomes Among Newly Diagnosed Hodgkin Lymphoma Patients Presenting with Unfavorable and Advanced Disease within a US Community Oncology Setting

Christopher A. Yasenchak, MD, Joseph Feliciano, PharmD, Kathleen M. Aguilar, MPH, Jamyia Clark, MPH, E Susan Amirian, PhD MS, Akshara Richhariya, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5177.
https://doi.org/10.1182/blood.V130.Suppl_1.5177.5177
Published: 2017